Compare Becton Dickinson and Co (BDX) vs iShares Broad USD Investment Grade Corporate Bond (USIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs iShares Broad USD Investment Grade Corporate Bond — how do they compare? Becton Dickinson and Co trades at $156.15 (market cap $41.51B), while iShares Broad USD Investment Grade Corporate Bond trades at $50.7. The key difference: Becton Dickinson and Co pays a 2.79% dividend while iShares Broad USD Investment Grade Corporate Bond pays none, and Becton Dickinson and Co is trading nearer its 52-week high, iShares Broad USD Investment Grade Corporate Bond nearer its low. Which is the better fit depends on your goals.
| BDX | USIG | |
|---|---|---|
Market Cap | $41.51B | — |
Sector | Health | Fixed Income |
52-Week High | $185.39 | $52.69 |
52-Week Low | $135.49 | $50.50 |
Enterprise Value | $57.97B | — |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
USIG trades at $50.50, down 0.4% with bearish technical signals from moving averages but oversold RSI readings. The ETF shows consistent dividend distributions with three payments scheduled for mid-2026. Short interest surged 63.4% in April 2026, indicating increased bearish sentiment among traders despite the investment-grade corporate bond focus.
The ETF faces headwinds from rising short interest and bearish technical momentum, though oversold conditions suggest potential near-term stabilization. Investment-grade corporate bond exposure provides relative safety, but interest rate sensitivity remains a key risk factor for fixed income ETFs in the current market environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About iShares Broad USD Investment Grade Corporate Bond
USIG is a low-cost ETF providing broad exposure to over 11,000 U.S. investment-grade corporate bonds. It tracks the ICE BofA US Corporate Index, featuring high-quality debt from 2026 leaders like Citigroup, Bank of America, and Oracle.
Read more on USIG →
